ABSTRACT

Retinopathy of prematurity is one of the most significant reasons of the childhood blindness in developing countries due to the rising numbers of preterm deliveries and improved neonatal care. The most important risk factors for PR are low birth weight and low gestational age. It is necessary for risky babies to be recognized by a screening program and to be followed by a trace program for PR. Peripheral retinal ablation is applied for therapy of PR. The functional results of surgical therapy are not promising. The results of intravitreal anti-VEGF injections alone or combined with peripheral retinal ablation become gradually encouranging.